We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

SenesTech Inc (SNES) USD0.001

Sell:$0.53 Buy:$0.55 Change: $0.0274 (4.73%)
Prices delayed by at least 15 minutes | Switch to live prices |
Change: $0.0274 (4.73%)
Prices delayed by at least 15 minutes | Switch to live prices |
Change: $0.0274 (4.73%)
Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

SenesTech, Inc. is developing and commercializing a global technology for managing animal pest populations, initially rat populations, through fertility control. The Company’s product ContraPest, is a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide (VCD) and triptolide. ContraPest limits the reproduction of male and female rats beginning with the first breeding cycle following consumption. ContraPest is a highly palatable liquid formulation that reduces fertility in both male and female rats. VCD is an occupational chemical that selectively destroys ovarian follicles in rats. The Company also continues to research and develop enhancements to ContraPest that align with its target verticals and other potential fertility control options for additional species. The Company is developing a fertility control product for mice. The Company has also developed preliminary data with feral dogs, feral pigs, wallabies and brushtail possums.

Contact details

3140 N Caden Ct Ste 1
United States
+1 (928) 7794143

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$7.21 million
Shares in issue:
12.21 million
United States
US dollar

Key personnel

  • Kenneth Siegel
    Chief Executive Officer, Director
  • Thomas Chesterman
    Chief Financial Officer, Executive Vice President, Treasurer, Assistant Secretary
  • Steven Krause
    Executive Vice President of Sales and Marketing
  • Kim Wolin
    Executive Vice President - Operations, Secretary
  • Nicole Williams
    Chief Strategy Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.